vimarsana.com
  1. Home
  2. Live Updates
  3. aTyr Pharma Announces Dosing of First Patient in Phase 2 EFZO-CONNECT™ Study of Efzofitimod in Patients with SSc-ILD : vimarsana.com

aTyr Pharma Announces Dosing of First Patient in Phase 2 EFZO-CONNECT™ Study of Efzofitimod in Patients with SSc-ILD

aTyr Pharma Announces Dosing of First Patient in Phase 2 EFZO-CONNECT™ Study of Efzofitimod in Patients with SSc-ILD

streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

United States , Ashlee Dunston , Sanjays Shukla , Public Affairs , European Union , Rheumatic Lung Disease Program , Drug Administration , Atyr Pharma Inc , Nasdaq , Tyr Pharma , Chief Executive Officer , Kristin Highland , Private Securities Litigation Reform Act , Annual Report , Quarterly Report , Investor Relations ,

© 2024 Vimarsana

vimarsana.com © 2020. All Rights Reserved.